sector medic suppli devic
reason fx could weigh ep
messag schedul announc result june ahead
report updat estim recent fx interest rate fluctuat
latest read contact len competit landscap despit on-going concern
histor advantag lens may erod amid increas focu
categori competitor consensu forecast appear achiev
view howev expect in-lin quarter see risk full year estim base
rate sit today lower forecast accordingli
street estim coopervis appear reason base intra-
quarter check model call sale yoy
organ vs current consensu forecast three major competitor
post organ sale growth weight averag basi calendar
best result sinc estim world-wide contact len market grew
underli basi modestli growth expect
deliv anoth quarter above-market growth compani face rel tough
comp europ still one quarter go start lap
easi comp domest result think like delta growth
broader market remain rel narrow gap shrunk
averag trend view indic
increasingli challeng competit landscap elsewher coopersurg estim
slightli ahead street vs consensu look
see whether paragard begin build momentum second quarter part
portfolio bottom line project adjust ep vs
consensu adjust currenc paragard accret forecast
actual impli declin underli earn
overal expect combin fx interest rate push
guidanc street estim lower current rate estim currenc could
ep tailwind compar manag guidanc
top line peg benefit vs guidanc meanwhil
higher interest rate could cost addit year
float rate debt rel assum back earli march take
account estim compani increment earn
headwind compar manag last updat outlook believ
absorb pressur lower ep estim
think like guidanc consensu
move lower come next week call new forecast impli full
year earn growth report basi underli gain
stock valuat look attract lack identifi catalyst
keep us sidelin share trade revis ntm ep estim
modest discount large-cap med-tech averag view
attract level rel compani long-term growth rate estim
top bottom line respect see potenti catalyst
horizon drive improv momentum stock competitor pois
launch sever import new product come month expect concern
contact len competit landscap continu weigh sentiment near-term
result maintain neutral rate
page analyst certif import disclosur
straddl line healthcar consum product contact
len women health busi coopervis portfolio uniqu posit take
advantag two tailwind drive contact len market growth today shift
premium len materi particular silicon hydrogel increas popular
daili dispos lens recent year leverag broadest daili sih
offer market lead posit monthli sih categori continu
long histori above-market growth compani captur averag
market share per year sinc expect gain moder go forward
backdrop competit contact len market believ cooper
remain well posit sustain growth
elsewher paragard deal add scale coopersurg grow women health
presenc often overlook investor expect csi account
overal revenu growth fuel
primarili compani invest half dozen deal
build lead posit ivf genet test market follow recent
acquisit paragard intrauterin devic believ long-term
fundament market appeal see grow scale csi neg
broader invest case complic stori believ
investor would prefer look sole contact len play
share current trade ntm ep ntm ebitda
repres modest discount large-cap med-tech group averag price-to-earnings basi
slight premium ev/ebitda view attract
level rel compani long-term growth rate estim
top bottom line respect see potenti catalyst horizon
drive improv momentum stock competitor pois launch sever
import new product come month expect concern contact len
competit landscap continu weigh sentiment near-term result
maintain neutral rate
upsid risk rate includ faster expect contact len market growth due
rise sih penetr daili len adopt increas share gain
busi better expect growth/accret paragard
downsid risk rate includ better anticip traction competit
contact len launch weaken macroeconom backdrop put pressur
cooper busi see discretionari med-tech market
potenti exposur tax reform rise interest rate
page analyst certif import disclosur
million usd except
good sold
compani report guggenheim secur llc estim
page analyst certif import disclosur
million usd
compani report guggenheim secur llc estim
page analyst certif import disclosur
